By Todd Cutler, MD
Faculty Peer Reviewed
A 62-year-old male is hospitalized with an acute congestive heart failure exacerbation. On hospital day three, the patient’s symptoms have significantly improved …
By Todd Cutler, MD
Faculty Peer Reviewed
A 62-year-old male is hospitalized with an acute congestive heart failure exacerbation. On hospital day three, the patient’s symptoms have significantly improved …
By Mary C. Whitman, MD
Faculty Peer Reviewed
Proton pump inhibitors (PPIs) are generally considered “safe†medications[1] and are prescribed to over 100 million patients per year for a variety of indications, often for …
By Antony Q. Pham, Pharm.D. and Reena M. Tejura, Pharm.D.
Faculty Peer Reviewed
Recent publications have described a potential drug interaction between clopidogrel (Plavix®) and proton pump inhibitors (PPIs). …
Diana Hubulashvili, Pharm.D.
Edited by Tania Ahuja, Pharm.D., BCPS
Read More
Marisa Mizus
Faculty peer reviewed
Clopidogrel (Plavix) has been the standard of care for patients with coronary artery disease following percutaneous coronary intervention (PCI) for the past decade. Although …

John Cruz
Faculty peer reviewed
A number of studies have shown that zolpidem (Ambien), the most commonly prescribed sleep-inducing medication on the market, can produce uncontrollable nocturnal …
Kanika Ballani, Pharm.D.
Diana Hubulasvili, Pharm.D.
 Developed by Amylin Pharmaceuticals, Exenatide (Byetta®) is an incretin mimetic that is used as an adjunctive therapy with metformin, a sulfonylurea or a thiazolidinedione to improve …

Frederick Gandolfo, MD
Case: An 85 year-old woman admitted to the hospital with pneumonia and after a prolonged hospital course developed heparin-induced thrombocytopenia (HIT). She …